Ottawa-based life sciences startup lands US$11.5M in fresh equity to fund cutting-edge cancer drugs
Orion Biotechnology is working on treatments that use the body’s immune system to target cancer, HIV, COVID-19 and other diseases.
Ottawa-based life sciences startup lands US$11.5M in fresh equity to fund cutting-edge cancer drugs
Orion Biotechnology is working on treatments that use the body’s immune system to target cancer, HIV, COVID-19 and other diseases.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
Do I need an engineer for my construction project?
What about the First Home Savings Account?
10 essential considerations when selling your business
EVENT ALERT: Mayor's Breakfast with Ontario Finance Minister on Wednesday, Dec. 4 @ City Hall